SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-406106
Filing Date
2014-11-10
Accepted
2014-11-10 16:27:16
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d782118d10q.htm 10-Q 387542
2 EX-31.1 d782118dex311.htm EX-31.1 6610
3 EX-31.2 d782118dex312.htm EX-31.2 6935
4 EX-32.1 d782118dex321.htm EX-32.1 4170
5 EX-32.2 d782118dex322.htm EX-32.2 4497
  Complete submission text file 0001193125-14-406106.txt   2303796

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acad-20140930.xml EX-101.INS 272441
7 XBRL TAXONOMY EXTENSION SCHEMA acad-20140930.xsd EX-101.SCH 25383
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20140930_cal.xml EX-101.CAL 42586
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20140930_def.xml EX-101.DEF 63314
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20140930_lab.xml EX-101.LAB 190933
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20140930_pre.xml EX-101.PRE 130064
Mailing Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 141209031
SIC: 2834 Pharmaceutical Preparations